GCM Grosvenor Inc Ordinary Shares - Class A GCMG 深 沪
已收盘 08-01 16:00:00 美东时间
11.67
-0.120
-1.02%
华盛通- 最 高11.77
- 今 开11.69
- 成交量 48.96万股
- 最 低 11.56
- 昨 收 11.79
- 总市值 5.83亿
- 52周最高 14.26
- 市盈率 静 340.23
- 换手率 0.98%
- 52周最低 9.71
- 委 比 13.64%
- 总股本 4999.44万
- 历史最高 14.26
- 量 比 1.52
- 振 幅 1.78%
- 历史最低 4.95
- 每 手 1
- 风险率 1.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多GCM Grosvenor to Announce Second Quarter 2025 Financial Results and Host Investor Conference Call on August 7, 2025
GCM Grosvenor will release its Q2 2025 results on August 7, 2025. Management will host a webcast and conference call at 11:00 a.m. ET on the same day to discuss the results and provide a business update. Registration and access details are available on the company's website. GCM Grosvenor, with $82 billion in assets under management, is a global alternative asset management firm offering solutions across multiple investment strategies. The firm h...
07-24 12:30
Wilshire Indexes and GCM Grosvenor Launch Private Market Infrastructure Index, Laying Foundation for Broader Strategic Alliance
Wilshire Indexes and GCM Grosvenor launched the FT Wilshire Private Markets Infrastructure Index, a first-of-its-kind benchmark for infrastructure investors, enabling passive exposure to a diversified universe of open-ended infrastructure funds. The index, created through collaboration, uses Wilshire's transparent methodologies and GCM Grosvenor's $82 billion platform. GCM Grosvenor plans to develop tracking vehicles. Future initiatives aim to en...
07-16 13:00
美股大行评级 | 潜在涨幅94.06%！摩根大通上调BioMarin制药目标价至113美元，维持"超配"评级
今日重点评级关注：摩根大通：维持BioMarin Pharmaceutical"超配"评级，目标价从108美元升至113美元；Oppenheimer：维持P10"跑赢大市"评级，目标价从20美元升至21美元
07-15 09:23
Sandra Buchanan Resigns from GCM Grosvenor
GCM Grosvenor ( ($GCMG) ) has shared an announcement. On July 9, 2025, Sandra B...
07-15 05:00
Oppenheimer Maintains Outperform on GCM Grosvenor, Raises Price Target to $19
Oppenheimer analyst Chris Kotowski maintains GCM Grosvenor (NASDAQ:GCMG) with a Outperform and raises the price target from $18 to $19.
07-15 00:19
GCM Grosvenor to Present at the Morgan Stanley 2025 U.S. Financials, Payments & CRE Conference on June 10, 2025
<p>GCM Grosvenor's President, Jon Levin, will present at the Morgan Stanley 2025 U.S. Financials, Payments & Commercial Real Estate Conference on June 10, 2025, at 3:15 PM EDT. The live audio webcast will be available on GCM Grosvenor’s public shareholders website and the event website. A replay will be accessible for 90 days post-presentation.</p> <p>GCM Grosvenor, with $82 billion in assets under management, specializes in alternative inves...
05-27 12:30
美股大行评级 | 潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
05-10 10:00
Oppenheimer Maintains Outperform on GCM Grosvenor, Raises Price Target to $17
Oppenheimer analyst Chris Kotowski maintains GCM Grosvenor (NASDAQ:GCMG) with a Outperform and raises the price target from $16 to $17.
05-10 01:26
Jacmel Partners Invests In LaGuardia Gateway Partners, Expanding Infrastructure Projects
Jacmel Partners ("Jacmel"), a minority-owned alternative investment firm, announced today that its Jacmel Infrastructure platform, with support from GCM Grosvenor (NASDAQ:GCMG), a global alternative asset management
05-09 21:09
